Olivetolic Acid
(Synonyms: 2,4-二羟基-6-戊基苯甲酸,Olivetolate, Olivetolcarboxylic Acid) 目录号 : GC41526
Olivetolic acid是一种天然聚酮化合物,为大麻中所有大麻素类物质的生物合成前体,可用于研究植物次生代谢及大麻素合成途径。
Cas No.:491-72-5
Sample solution is provided at 25 µL, 10mM.
Olivetolic acid is a natural polyketide compound that serves as the universal biosynthetic precursor of all cannabinoids in Cannabis sativa[1-2].
In a mouse model of Dravet syndrome Scn1a⁺/⁻, a single intraperitoneal injection of 10-100mg/kg of Olivetolic acid, Olivetolic acid (100mg/kg), significantly increased the temperature threshold of heat-induced tonic-clonic seizures by about 0.4°C, showing anticonvulsant effects[3].
References:
[1] Giangrossi M, Salamone S, Camola A, et al. Taglialatela-Scafati O, Chianese G, Gargiulo E, Nabissi M, Pollastro F. Biomimetic synthesis of rare cannabigerol-type cannabinoids and evaluation of their cytotoxic effect on human glioblastoma cell lines. Fitoterapia. 2025 Mar;181:106354.
[2] Ismed F, Farhan A, Bakhtiar A, et al. Crystal structure of olivetolic acid: a natural product from Cetrelia sanguinea (Schaer.). Acta Crystallogr E Crystallogr Commun. 2016 Oct 18;72(Pt 11):1587-1589.
[3] Anderson LL, Udoh M, Everett-Morgan D, et al. Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome. J Cannabis Res. 2022 Jan 4;4(1):2.
Olivetolic acid是一种天然聚酮化合物,为大麻中所有大麻素类物质的生物合成前体,可用于研究植物次生代谢及大麻素合成途径[1-2]。
在Dravet综合征Scn1a⁺/⁻小鼠模型中,单次腹腔注射10-100mg/kg的Olivetolic acid,Olivetolic acid(100mg/kg)可显著提高热诱导强直-阵挛发作的温度阈值约0.4°C,表现出抗惊厥效果[3]。
Animal experiment [1]: | |
Animal models | Scn1a+/- mice |
Preparation Method | Mice were acclimated to a rectal temperature probe for 5min, then received a single intraperitoneal injection of vehicle or Olivetolic acid (10–100mg/kg). Immediately afterward, core body temperature was elevated 0.5°C every 2min until the first generalized tonic-clonic seizure (GTCS) with loss of posture or until 42.5°C was reached. |
Dosage form | 10–100mg/kg; i.p. |
Applications | Olivetolic acid modestly but significantly increased the hyperthermia-induced seizure threshold in Scn1a+/- mice, indicating anticonvulsant activity comparable to cannabidiol at the same dose. |
References: |
Cas No. | 491-72-5 | SDF | |
别名 | 2,4-二羟基-6-戊基苯甲酸,Olivetolate, Olivetolcarboxylic Acid | ||
化学名 | 2,4-dihydroxy-6-pentyl-benzoic acid | ||
Canonical SMILES | OC1=CC(O)=C(C(O)=O)C(CCCCC)=C1 | ||
分子式 | C12H16O4 | 分子量 | 224.3 |
溶解度 | 50mg/mL in DMSO, 50mg/mL in DMF, 50mg/mL in Ethanol | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 4.4583 mL | 22.2916 mL | 44.5831 mL |
5 mM | 0.8917 mL | 4.4583 mL | 8.9166 mL |
10 mM | 0.4458 mL | 2.2292 mL | 4.4583 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet